Mohamed E. Ashour
Impact in
-
- Lung Cancer Research Studies
- PARP inhibition in cancer therapy
Papers in
-
- Cancer therapeutics and mechanisms 6
- DNA Repair Mechanisms 4
- Epigenetics and DNA Methylation 2
- Oncology 4
- Polyomavirus and related diseases 2
- PARP inhibition in cancer therapy 2
- Cancer Treatment and Pharmacology 1
- Co-authors
- Sherif F. El‐Khamisy (6 shared papers)Nima Mosammaparast (3 shared papers)Iman H. Bassyouni (2 shared papers)Roba M. Talaat (2 shared papers)Chunyan Liao (2 shared papers)Ahmed A. Raouf (1 shared paper)Oliver Flouty (1 shared paper)Mahmoud Tarek Hefnawy (1 shared paper)
- Journals
- Nucleic Acids Research (2 papers)The Journal of Cell Biology (1 paper)Nature reviews. Cancer (1 paper)Immunobiology (1 paper)Advances in experimental medicine and biology (1 paper)
- Partner nations
- EgyptUnited KingdomUnited States
In The Last Decade
Mohamed E. Ashour
13 papers receiving 436 citations
Mohamed E. Ashour's Hit Papers
Peers
Comparison fields: 5 of 113
- Toxicology 15
- Oncology 113
- Molecular Biology 277
- Ophthalmology 31
- Health Informatics 4
Countries citing papers authored by Mohamed E. Ashour
This map shows the geographic impact of Mohamed E. Ashour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed E. Ashour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed E. Ashour more than expected).
Fields of papers citing papers by Mohamed E. Ashour
This network shows the impact of papers produced by Mohamed E. Ashour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed E. Ashour. The network helps show where Mohamed E. Ashour may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohamed E. Ashour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 135 | |
| 2 | Appraising systematic reviews: a comprehensive guide to ensuring validity and reliability Hit paper breakdown → | 2023 | 70 |
| 3 | 2018 | 49 | |
| 4 | 2016 | 46 | |
| 5 | 2021 | 42 | |
| 6 | 2014 | 39 | |
| 7 | 2015 | 23 | |
| 8 | 2016 | 21 | |
| 9 | 2023 | 7 | |
| 10 | 2021 | 4 | |
| 11 | 2023 | 1 | |
| 12 | 2014 | 1 | |
| 13 | 2017 | 1 |
About Mohamed E. Ashour
Mohamed E. Ashour is a scholar working on Molecular Biology, Oncology, Rheumatology, General Health Professions and Sociology and Political Science, having authored 13 papers that have together received 439 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (6 papers), DNA Repair Mechanisms (4 papers), Polyomavirus and related diseases (2 papers), Epigenetics and DNA Methylation (2 papers), Systemic Lupus Erythematosus Research (2 papers), PARP inhibition in cancer therapy (2 papers), Atherosclerosis and Cardiovascular Diseases (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Toxicology (15 citations), Oncology (113 citations), Molecular Biology (277 citations), Ophthalmology (31 citations) and Health Informatics (4 citations). Mohamed E. Ashour has collaborated with scholars based in Egypt, United Kingdom and United States. Frequent co-authors include Sherif F. El‐Khamisy, Nima Mosammaparast, Iman H. Bassyouni, Roba M. Talaat, Chunyan Liao, Ahmed A. Raouf, Oliver Flouty, Mahmoud Tarek Hefnawy, Ahmed Shaheen and Ismail Ibrahim. Their work appears in journals such as Nucleic Acids Research, The Journal of Cell Biology, Nature reviews. Cancer, Immunobiology and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.